Hjem › Brystkreft › Connecticut › Stamford
Kliniske studier for Brystkreft i Stamford, CT
9 studier for Brystkreft søker deltakere på steder i og rundt Stamford (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruttererFase 3
- Stamford Hospital ( Site 0049), Stamford
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- Smilow Cancer Hospital Care Center - Greenwich, Greenwich · 5 mi unna
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruttererFase 3
- Paradigm New York Cancer and Blood Specialists, Bay Shore · 27 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Stamford Hospital/Bennett Cancer Center, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi unna
- og 3 flere
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekruttererFase 2
- Stamford Hospital, Stamford
- Smilow Cancer Hospital Care center at Greenwich, Greenwich · 5 mi unna
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- Stamford Hospital/Bennett Cancer Center, Stamford
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Smilow Cancer Hospital - Long Ridge, Stamford
- Smilow Cancer Hospital - Greenwich, Greenwich · 5 mi unna
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RekruttererFase 2
- Stamford Hospital, Stamford
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi unna
- Northwell Health Cancer Institute at Huntington, Greenlawn · 16 mi unna
- og 1 flere
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Stamford
- Lungekreft10 studier
- Ikke-småcellet lungekreft8 studier
- Migrene6 studier
- Fedme6 studier
- Prostatakreft5 studier
- Eggstokkreft5 studier
- Pankreaskreft4 studier
- Kardiovaskulær sykdom4 studier
- Overvekt4 studier
- Metastatisk kreft3 studier
- Nevrologiske sykdommer3 studier
- Hjertesvikt3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.